Tyrosine Kinase Inhibitors Global Market Report 2023
Including: 1) By Type: BCR-ABL Tyrosine Kinase Inhibitor; Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors; Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors2) By Distribution Channel: Hospital Pharmacy; Independent Pharmacies; Online Pharmacies3) By Application: Chronic Myeloid Leukemia (CML); Lung Cancer; Breast Cancer; Renal Cell CancerCovering: Pfizer Inc.; Johnson And Johnson Private Limited.; F. Hoffmann-La Roche AG; AbbVie Inc.; Bayer AG
Tyrosine Kinase Inhibitors Global Market Report 2023 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on tyrosine kinase inhibitors market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
- Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
- Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
- Assess the Russia – Ukraine war’s impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
- Measure the impact of high global inflation on market growth.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for tyrosine kinase inhibitors? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tyrosine kinase inhibitors market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
Scope
Markets Covered:1) By Type: BCR-ABL Tyrosine Kinase Inhibitor; Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors; Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors; Other Types
2) By Distribution Channel: Hospital Pharmacy; Independent Pharmacies; Online Pharmacies
3) By Application: Chronic Myeloid Leukemia (CML); Lung Cancer; Breast Cancer; Renal Cell Cancer; Other Applications
Companies Mentioned: Pfizer Inc.; Johnson And Johnson Private Limited.; F. Hoffmann-La Roche AG; AbbVie Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.
- 1. Executive Summary
- 2. Tyrosine Kinase Inhibitors Market Characteristics
- 3. Tyrosine Kinase Inhibitors Market Trends And Strategies
- 4. Tyrosine Kinase Inhibitors Market - Macro Economic Scenario
- 4.1. Impact Of High Inflation On Online Therapy Services Market
- 4.2. Ukraine-Russia War Impact On Online Therapy Services Market
- 4.3. COVID-19 Impact On Online Therapy Services Market
- 5.1. Global Tyrosine Kinase Inhibitors Historic Market Size and Growth, 2017 - 2022, Value ($ Billion)
- 5.2. Global Tyrosine Kinase Inhibitors Forecast Market Size and Growth, 2022 - 2027, 2032F, Value ($ Billion)
- 5.3. Global Tyrosine Kinase Inhibitors Market Drivers and Restraints
- 5.3.1. Drivers Of The Market
- 5.3.2. Restraints Of The Market
- 6. Tyrosine Kinase Inhibitors Market Segmentation
- 6.1. Global Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- BCR-ABL Tyrosine Kinase Inhibitor
- Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitors
- Vascular Endothelial Growth Factor Receptor (VEGFR) Tyrosine Kinase Inhibitors
- Other Types
- 6.2. Global Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Hospital Pharmacy
- Independent Pharmacies
- Online Pharmacies
- 6.3. Global Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- Chronic Myeloid Leukemia (CML)
- Lung Cancer
- Breast Cancer
- Renal Cell Cancer
- Other Applications
- 7. Tyrosine Kinase Inhibitors Market Regional And Country Analysis
- 7.1. Global Tyrosine Kinase Inhibitors Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 7.2. Global Tyrosine Kinase Inhibitors Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8. Asia-Pacific Tyrosine Kinase Inhibitors Market
- 8.1. Asia-Pacific Tyrosine Kinase Inhibitors Market Overview
- Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
- 8.2. Asia-Pacific Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8.3. Asia-Pacific Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 8.4. Asia-Pacific Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 9. China Tyrosine Kinase Inhibitors Market
- 9.1. China Tyrosine Kinase Inhibitors Market Overview
- 9.2. China Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 9.3. China Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 9.4. China Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
- 10. India Tyrosine Kinase Inhibitors Market
- 10.1. India Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 10.2. India Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 10.3. India Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11. Japan Tyrosine Kinase Inhibitors Market
- 11.1. Japan Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11.2. Japan Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 11.3. Japan Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12. Australia Tyrosine Kinase Inhibitors Market
- 12.1. Australia Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12.2. Australia Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 12.3. Australia Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13. Indonesia Tyrosine Kinase Inhibitors Market
- 13.1. Indonesia Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13.2. Indonesia Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 13.3. Indonesia Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14. South Korea Tyrosine Kinase Inhibitors Market
- 14.1. South Korea Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14.2. South Korea Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 14.3. South Korea Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15. Western Europe Tyrosine Kinase Inhibitors Market
- 15.1. Western Europe Tyrosine Kinase Inhibitors Market Overview
- 15.2. Western Europe Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15.3. Western Europe Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 15.4. Western Europe Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16. UK Tyrosine Kinase Inhibitors Market
- 16.1. UK Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16.2. UK Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 16.3. UK Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17. Germany Tyrosine Kinase Inhibitors Market
- 17.1. Germany Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17.2. Germany Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 17.3. Germany Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18. France Tyrosine Kinase Inhibitors Market
- 18.1. France Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18.2. France Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 18.3. France Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19. Italy Tyrosine Kinase Inhibitors Market
- 19.1. Italy Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19.2. Italy Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 19.3. Italy Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20. Spain Tyrosine Kinase Inhibitors Market
- 20.1. Spain Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20.2. Spain Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 20.3. Spain Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21. Eastern Europe Tyrosine Kinase Inhibitors Market
- 21.1. Eastern Europe Tyrosine Kinase Inhibitors Market Overview
- 21.2. Eastern Europe Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21.3. Eastern Europe Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 21.4. Eastern Europe Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22. Russia Tyrosine Kinase Inhibitors Market
- 22.1. Russia Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22.2. Russia Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 22.3. Russia Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23. North America Tyrosine Kinase Inhibitors Market
- 23.1. North America Tyrosine Kinase Inhibitors Market Overview
- 23.2. North America Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23.3. North America Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 23.4. North America Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24. USA Tyrosine Kinase Inhibitors Market
- 24.1. USA Tyrosine Kinase Inhibitors Market Overview
- 24.2. USA Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24.3. USA Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 24.4. USA Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25. Canada Tyrosine Kinase Inhibitors Market
- 25.1. Canada Tyrosine Kinase Inhibitors Market Overview
- 25.2. Canada Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25.3. Canada Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 25.4. Canada Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26. South America Tyrosine Kinase Inhibitors Market
- 26.1. South America Tyrosine Kinase Inhibitors Market Overview
- 26.2. South America Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26.3. South America Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 26.4. South America Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27. Brazil Tyrosine Kinase Inhibitors Market
- 27.1. Brazil Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27.2. Brazil Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 27.3. Brazil Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28. Middle East Tyrosine Kinase Inhibitors Market
- 28.1. Middle East Tyrosine Kinase Inhibitors Market Overview
- 28.2. Middle East Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28.3. Middle East Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 28.4. Middle East Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29. Africa Tyrosine Kinase Inhibitors Market
- 29.1. Africa Tyrosine Kinase Inhibitors Market Overview
- 29.2. Africa Tyrosine Kinase Inhibitors Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29.3. Africa Tyrosine Kinase Inhibitors Market, Segmentation By Distribution Channel, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 29.4. Africa Tyrosine Kinase Inhibitors Market, Segmentation By Application, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
- 30. Tyrosine Kinase Inhibitors Market Competitive Landscape And Company Profiles
- 30.1. Tyrosine Kinase Inhibitors Market Competitive Landscape
- 30.2. Tyrosine Kinase Inhibitors Market Company Profiles
- 30.2.1. Pfizer Inc.
- 30.2.1.1. Overview
- 30.2.1.2. Products and Services
- 30.2.1.3. Strategy
- 30.2.1.4. Financial Performance
- 30.2.2. Johnson And Johnson Private Limited.
- 30.2.2.1. Overview
- 30.2.2.2. Products and Services
- 30.2.2.3. Strategy
- 30.2.2.4. Financial Performance
- 30.2.3. F. Hoffmann-La Roche AG
- 30.2.3.1. Overview
- 30.2.3.2. Products and Services
- 30.2.3.3. Strategy
- 30.2.3.4. Financial Performance
- 30.2.4. AbbVie Inc.
- 30.2.4.1. Overview
- 30.2.4.2. Products and Services
- 30.2.4.3. Strategy
- 30.2.4.4. Financial Performance
- 30.2.5. Bayer AG
- 30.2.5.1. Overview
- 30.2.5.2. Products and Services
- 30.2.5.3. Strategy
- 30.2.5.4. Financial Performance
- 31. Tyrosine Kinase Inhibitors Market Other Major And Innovative Companies
- 31.1. Novartis AG
- 31.2. Sanofi S.A.
- 31.3. Bristol-Myers Squibb Company
- 31.4. AstraZeneca Plc.
- 31.5. GlaxoSmithKline plc
- 31.6. Eli Lilly and Company
- 31.7. Amgen Inc.
- 31.8. Boehringer Ingelheim International GmbH
- 31.9. Teva Pharmaceutical Industries Ltd.
- 31.10. Regeneron Pharmaceuticals Inc.
- 31.11. Astellas Pharma Inc.
- 31.12. Eisai Co. Ltd
- 31.13. Incyte Corporation
- 31.14. Dr. Reddy's Laboratories Ltd.
- 31.15. Exelixis Inc.
- 32. Global Tyrosine Kinase Inhibitors Market Competitive Benchmarking
- 33. Global Tyrosine Kinase Inhibitors Market Competitive Dashboard
- 34. Key Mergers And Acquisitions In The Tyrosine Kinase Inhibitors Market
- 35. Tyrosine Kinase Inhibitors Market Future Outlook and Potential Analysis
- 35.1 Tyrosine Kinase Inhibitors Market In 2027 - Countries Offering Most New Opportunities
- 35.2 Tyrosine Kinase Inhibitors Market In 2027 - Segments Offering Most New Opportunities
- 35.3 Tyrosine Kinase Inhibitors Market In 2027 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies
- 36. Appendix
- 36.1. Abbreviations
- 36.2. Currencies
- 36.3. Historic And Forecast Inflation Rates
- 36.4. Research Inquiries
- 36.5. The Business Research Company
- 36.6. Copyright And Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook